Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis

Published:2018-02-19 Issue:4 Volume:67 Page:1485-1498
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

García-Lezana Teresa¹,Raurell Imma¹²,Bravo Miren¹²,Torres-Arauz Manuel¹,Salcedo María Teresa³,Santiago Alba⁴,Schoenenberger Andreu⁴,Manichanh Chaysavanh²⁴,Genescà Joan¹²^ORCID,Martell María¹²,Augustin Salvador¹²

Affiliation:

1. Liver Unit, Department of Internal Medicine; Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona; Barcelona Spain

2. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III; Madrid Spain

3. Department of Pathology; Hospital Universitari Vall d'Hebron

4. Digestive System Research Unit, Institut de Recerca Vall d'Hebron; Barcelona Spain

Funder

Instituto de Salud Carlos III

Vall d'Hebron Institut de Recerca

European Union

European Union (ERDF/ESF, “Investing in your future”)

Publisher

Wiley

Subject

Hepatology

Reference29 articles.

1. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis;Berzigotti;Hepatology,2011

2. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study;Berzigotti;Hepatology,2017

3. Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis;Francque;Eur J Gastroenterol Hepatol,2010

4. Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease;Mendes;Clin Gastroenterol Hepatol,2012

5. Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension;Francque;Int J Obes,2011

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effect of fecal microbiota transplantation on rats with liver cirrhosis and its influence on gut microbiota;IRAN J BASIC MED SCI;2024

2. Assessing the Therapeutic Potential of Fecal Microbiota Transplantation in Steatotic Liver Disease: Current Insights and Future Pathways;Current Hepatology Reports;2024-07-29

3. Fructooligosaccharides reverses hepatic vascular dysfunction and dysbiosis in rats with liver cirrhosis and portal hypertension;European Journal of Clinical Investigation;2024-07-17

4. Therapeutic manipulation of the microbiome in liver disease;Hepatology;2024-06-26

5. Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective;Metabolites;2024-06-07